UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-09 | Future report Set alerts | |
| Q2 2022 | 2022-08-18 | 1.86 | 1.86 |
| Q1 2022 | 2022-05-12 | 1.80 | 1.80 |
| Q4 2021 | 2022-02-17 | 1.73 | 1.73 |
| Q3 2021 | 2021-11-11 | 1.68 | 1.68 |
| Q2 2021 | 2021-08-05 | 1.57 | 1.57 |
| Q1 2021 | 2021-05-13 | 1.54 | 1.54 |
| Q4 2020 | 2021-02-18 | 1.61 | 1.61 |
| Q3 2020 | 2020-11-12 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-06 | 1.37 | 0.68 |
| 2016-06-30 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-06-29 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $74.00 |
| 2016-06-23 | Reiterated Rating | Oppenheimer | Buy | $75.00 |
| 2016-06-23 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | $75.00 |
| 2016-06-22 | Initiated Coverage | Chardan Capital | Buy | $63.00 |
| 2016-05-26 | Upgrade | JMP Securities | Market Perform to Outperform | $78.00 |
| 2016-05-26 | Reiterated Rating | Oppenheimer | Buy | $75.00 |
| 2016-05-26 | Upgrade | JPMorgan Chase & Co. | Market Perform to Outperform | $78.00 |
| 2016-05-18 | Reiterated Rating | Oppenheimer | Buy | $75.00 |
| 2016-02-12 | Reiterated Rating | Oppenheimer | Outperform | $75.00 |
| 2016-02-12 | Lower Price Target | RBC Capital | Sector Perform | $72.00 to $68.00 |
| 2016-02-12 | Lower Price Target | Royal Bank Of Canada | Sector Perform | $72.00 to $68.00 |
| 2016-01-19 | Reiterated Rating | Imperial Capital | Outperform | $74.00 |
| 2016-01-13 | Reiterated Rating | Oppenheimer | Outperform | $75.00 |
| 2015-11-19 | Reiterated Rating | Oppenheimer | Outperform | $75.00 |
| 2015-11-02 | Boost Price Target | Imperial Capital | Outperform | $52.00 to $65.00 |
| 2015-11-01 | Reiterated Rating | FBR & Co. | Outperform | $69.00 |
| 2015-11-01 | Reiterated Rating | FBR & Co | Outperform | $69.00 |
| 2015-10-30 | Boost Price Target | RBC Capital | Sector Perform | $68.00 to $72.00 |
| 2015-09-03 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $72.00 to $68.00 |
| 2015-07-30 | Reiterated Rating | FBR & Co. | Outperform | $68.00 to $69.00 |
| 2015-06-30 | Reiterated Rating | Oppenheimer | Buy | $75.00 |
| 2015-06-04 | Set Price Target | Oppenheimer | Buy | $75.00 |
| 2015-06-03 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $68.00 to $72.00 |
| 2015-06-02 | Set Price Target | FBR & Co. | Buy | $68.00 |
| 2015-05-24 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $64.00 to $68.00 |
| 2015-05-23 | Reiterated Rating | Imperial Capital | Outperform | $65.00 to $74.00 |
| 2015-05-21 | Reiterated Rating | Oppenheimer | Buy | $69.00 to $75.00 |
| 2015-05-12 | Reiterated Rating | Imperial Capital | Outperform | $65.00 to $74.00 |
| 2015-05-10 | Reiterated Rating | Oppenheimer | Outperform | $69.00 |
| 2015-05-08 | Boost Price Target | Barclays | Equal Weight | $55.00 to $60.00 |
| 2015-05-08 | Boost Price Target | RBC Capital | Sector Perform | $57.00 to $68.00 |
| 2015-05-08 | Reiterated Rating | FBR & Co. | Outperform | $68.00 |
| 2015-05-08 | Boost Price Target | Barclays PLC | Equal Weight | $55.00 to $60.00 |
| 2015-04-28 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $56.00 to $60.00 |
| 2015-03-24 | Downgrade | JMP Securities | Outperform to Market Perform | $58.00 |
| 2015-03-23 | Boost Price Target | Oppenheimer | Outperform | $60.00 to $69.00 |
| 2015-02-12 | Upgrade | Barclays | Underweight to Equal Weight | $35.00 to $55.00 |
| 2015-02-11 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $56.00 |
| 2015-02-11 | Boost Price Target | Imperial Capital | Outperform | $52.00 to $65.00 |
| 2015-02-06 | Boost Price Target | FBR & Co. | Outperform | $56.00 to $59.00 |
| 2015-01-16 | Boost Price Target | FBR & Co. | Outperform | $50.00 to $56.00 |
| 2014-11-06 | Boost Price Target | Imperial Capital | Outperform | $48.00 to $52.00 |
| 2014-11-05 | Boost Price Target | FBR & Co. | Outperform | $46.00 to $50.00 |
| 2014-05-09 | Lower Price Target | Wedbush | $47.00 to $45.00 | |
| 2014-05-09 | Downgrade | CRT Capital | Buy to Fair Value | $46.00 to $40.00 |
| 2014-04-30 | Boost Price Target | Imperial Capital | Outperform | $43.00 to $48.00 |
| 2014-04-01 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $46.00 to $49.00 |
| 2013-10-31 | Downgrade | Barclays | Equal Weight to Underweight | $40.00 to $35.00 |
| 2013-09-26 | Initiated Coverage | Wedbush | Outperform | $47.00 |
| 2013-03-21 | Resumed | Imperial Capital | Outperform | $43 |
| 2013-02-19 | Reiterated | Imperial Capital | Outperform | $44 to $43 |
| 2013-02-13 | Reiterated | FBR Capital | Outperform | $38 to $40 |
| 2012-03-28 | Reiterated | FBR Capital | Outperform | $41 to $45 |
| 2012-02-15 | Reiterated | FBR Capital | Outperform | $38 to $41 |
| 2011-04-05 | Downgrade | Barclays Capital | Overweight to Equal Weight | $42 to $42 |
| 2011-02-22 | Reiterated | HSBC Securities | Overweight | $41 to $45 |
| 2011-02-17 | Reiterated | Barclays Capital | Overweight | $39 to $42 |
| 2011-02-11 | Reiterated | RBC Capital Mkts | Outperform | $38 to $40 |
| 2010-11-19 | Upgrade | HSBC Securities | Neutral to Overweight | $37 to $41 |
| 2010-10-28 | Reiterated | Barclays Capital | Overweight | $37 to $39 |
| 2010-03-26 | Reiterated | Oscar Gruss | Buy | $37 to $38 |
| 2010-03-24 | Downgrade | Morgan Keegan | Outperform to Mkt Perform | |
| 2009-10-27 | Reiterated | Oppenheimer | Outperform | $35 to $38 |
| 2009-09-15 | Reiterated | FBR Capital | Outperform | $30 to $34 |
| 2009-09-08 | Upgrade | UBS | Neutral to Buy | |
| 2009-07-30 | Upgrade | Oscar Gruss | Hold to Buy | $21 to $32 |
| 2009-04-13 | Reiterated | FBR Capital Markets | Outperform | $25 to $30 |
| 2009-02-13 | Downgrade | UBS | Buy to Neutral | |
| 2008-11-12 | Reiterated | Oscar Gruss | Hold | $33 to $23 |
| 2016-06-30 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2016-06-29 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $74.00 |
| 2016-06-23 | Reiterated Rating | Oppenheimer | Buy | $75.00 |
| 2016-06-23 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | $75.00 |
| 2016-06-22 | Initiated Coverage | Chardan Capital | Buy | $63.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In NICE 238 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Capital Research Global Investors | 7.15M |
| JANUS CAPITAL MANAGEMENT LLC | 4.48M |
| FMR LLC | 3.55M |
| OPPENHEIMER FUNDS INC | 2.69M |
| HENDERSON GROUP PLC | 2.50M |
| Capital International Investors | 1.59M |
| Artisan Partners Limited Partnership | 1.42M |
| BlackRock Inc. | 0.92M |
| RIVULET CAPITAL, LLC | 0.88M |
| CITADEL ADVISORS LLC | 0.87M |
| FRANKLIN RESOURCES INC | 0.85M |
| RGM Capital, LLC | 0.73M |
| Invesco Ltd. | 0.68M |
| BESSEMER GROUP INC | 0.64M |
| Black Creek Investment Management Inc. | 0.61M |
UM